| HOME >> BIOLOGY >> TECHNOLOGY |
income 57,936 455,801
Interest income, net -- (927,054)
Amortization of debt discount
and financing costs
Interest expense on convertible
notes -- (255,309)
Net Loss $(2,537,419) $(29,342,424)
Basic and Diluted Net Loss Per
Common Share $(0.15)
Basic and Diluted Weighted
Average Number of Common
Shares Outstanding 16,732,003
SENESCO TECHNOLOGIES, INC. AND SUBSIDIARY
(A DEVELOPMENT STAGE COMPANY)
CONDENSED CONSOLIDATED BALANCE SHEETS
March 31, June 30,
2008 2007
(unaudited)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents $4,049,233 $408,061
Short-term investments 500,000 250,000
Prepaid expenses and other current assets 57,695 104,526
Total Current Assets 4,606,928 762,587
Property and equipment, net 6,880 7,526
Intangibles, net 3,032,449 2,544,447
Deferred financing costs 729,029 --
Security deposit 7,187 7,187
TOTAL ASSETS $8,382,473 $3,321,747
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable $168,525 $109,258
Accrued expenses 509,619 377,359
Deferred revenue
'/>"/>
| SOURCE Senesco Technologies, Inc. Copyright©2008 PR Newswire. All rights reserved |